Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €11.45 EUR
Change Today +0.04 / 0.35%
Volume 1.9K
As of 11:18 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Louis Dasseux Ph.D., M.B.A.

Co-Founder, Chief Executive Officer and Director, Cerenis Therapeutics Holding SA
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 2 different industries.

See Board Relationships
55--

Background*

Dr. Jean-Louis H. Dasseux, Ph.D., serves as President and Chief Executive Officer of Cerenis Therapeutics SA. Dr. Dasseux founded Cerenis Therapeutics SA in 2005. He served as Vice President, Chemistry and Technologies of Esperion Therapeutics Inc. since August 2000, after serving as Senior Director of Chemistry since January 1999. Dr. Dasseux has more than 15 years of experience in the pharmaceutical industry focusing on chemistry, lipoprotein metabolism and atherosclerosis. ...

Read Full Background

Corporate Headquarters*

265 rue de la Decouverte - Bat. A
Labege, Midi-Pyrénées 31670

France

Phone: 33 5 62 24 97 06
Fax: 33 5 62 19 04 17

Board Members Memberships*

Co-Founder, Chief Executive Officer and Director

Education*

Doctorate
The University of Tennessee
MS
University of Bordeaux
PhD
University of Bordeaux
Doctorate
Université Laval

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEREN:FP €11.45 EUR +0.04

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CERENIS THERAPEUTICS HOLDING, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.